4 free views remaining today
posterior fossa group B ependymoma
Description
Posterior fossa group B (PFB) ependymomas are a type of brain tumor that occurs in the posterior fossa, which is the lower half of the brain. They are more common among adolescent and adult populations, with a median age of approximately 30 years [3].
These tumors occur either within the ventricle or in the central canal of the spinal cord, causing distention [5]. PFB ependymomas have distinct molecular characteristics, including DNA methylation patterns that differ from those found in posterior fossa group A (PFA) ependymomas [9].
The prognosis and treatment outcomes for PFB ependymomas are generally poorer compared to PFA ependymomas. They comprise a significant portion of posterior fossa ependymomas, which are the most common type of ependymoma overall, although rare in adults [6].
Additional Characteristics
- Posterior fossa group B (PFB) ependymomas
- Type of brain tumor that occurs in the posterior fossa
- More common among adolescent and adult populations
- Median age approximately 30 years
- Occur within the ventricle or central canal of the spinal cord
- Cause distention
- Distinct molecular characteristics, including DNA methylation patterns
- Poorer prognosis and treatment outcomes compared to PFA ependymomas
Signs and Symptoms
Posterior Fossa Group B Ependymoma Signs and Symptoms
The signs and symptoms of posterior fossa group B ependymoma can vary, but common presentations include:
- Ataxia: A lack of coordination and balance, which can lead to difficulty walking or maintaining posture [3].
- Nystagmus: An involuntary movement of the eyes, which can be a sign of increased intracranial pressure [2].
- Papilledema: Swelling of the optic disc, which can indicate raised intracranial pressure [8].
- Progressive lethargy, headache, nausea, and vomiting; these symptoms can occur in children with masses in the fourth ventricle [7].
In some cases, children who have surgery for ependymoma may develop posterior fossa syndrome, which includes changes in behavior, difficulty speaking, and other neurological symptoms [4].
Diagnostic Tests
Diagnosing Posterior Fossa Group B Ependymoma
Posterior fossa group B (PFB) ependymomas are a type of brain tumor that requires accurate diagnosis for effective treatment. The diagnostic tests used to diagnose PFB ependymoma include:
- Imaging studies: Magnetic Resonance Imaging (MRI) with contrast enhancement is the modality of choice for diagnosing ependymal tumors [3]. MRI can help visualize the tumor's location, size, and extent.
- Computed Tomography (CT): CT scans can better depict calcifications, which are common in ependymomas [3].
- Molecular testing: Because there are different types of ependymomas, molecular testing must occur on your child's tumor to get a correct diagnosis. This is especially true for PFB ependymoma group B [8].
Additional Diagnostic Tests
Other tests may be used in conjunction with these imaging studies and molecular testing to confirm the diagnosis:
- Diffusion-weighted imaging: This type of imaging may be useful for differentiating pilocytic astrocytomas, medulloblastomas, and ependymomas in the posterior fossa [2].
- MR spectroscopy: This test can provide additional information about the tumor's metabolic activity.
Early Detection and Diagnosis
Accurate diagnosis is crucial for effective treatment of PFB ependymoma. Early detection through these diagnostic tests can improve patient outcomes.
References:
[1] Not available in context
[2] by R Rudà · 2018 · Cited by 275 — Diffusion-weighted imaging may be useful for differentiating pilocytic astrocytomas, medulloblastomas, and ependymomas in the posterior fossa.
[3] by R Rudà · 2022 · Cited by 69 — MRI with contrast enhancement is the modality of choice for diagnosing ependymal tumors [21, 22]. CT can better depict calcifications, which are ...
[8] Because there are different types of ependymomas, molecular testing must occur on your child's tumor to get a correct diagnosis. Common types of ependymoma in ...
Additional Diagnostic Tests
- Molecular testing
- Imaging studies (MRI and CT)
- Diffusion-weighted imaging
- MR spectroscopy
Treatment
Treatment Options for Posterior Fossa Group B Ependymoma
Posterior fossa group B (PFB) ependymomas are a type of brain tumor that can be challenging to treat. While surgery and radiotherapy are the mainstay of treatment, drug therapy may also play a role in managing this condition.
Chemotherapy
Traditional chemotherapy has been used to treat ependymoma, but the results have been mixed [6]. However, some studies suggest that chemotherapy may be effective in certain cases, particularly when combined with surgery and radiotherapy [9].
Targeted Therapy
Targeted therapy is a type of treatment that uses drugs or other substances to specifically target cancer cells. While there are no specific targeted therapies approved for the treatment of PFB ependymoma, researchers are exploring various options, including those that target the PI3K/AKT pathway [1].
Immunotherapy
Immunotherapy involves using the body's immune system to fight cancer. Researchers are investigating immunotherapies, such as checkpoint inhibitors, to treat PFB ependymoma [5].
Current Treatment Guidelines
The primary treatment modality for ependymoma is surgical resection, followed by radiation therapy [7]. However, some studies suggest that patients with posterior fossa B ependymoma may be sufficiently treated with gross-total resection alone [14].
Future Directions
While there are no specific drug treatments approved for the treatment of PFB ependymoma, researchers are actively exploring various options. Further research is needed to determine the most effective treatment strategies for this condition.
References:
[1] Context 11 [5] Context 9 [6] Context 6 [7] Context 7 [14] Context 14
Recommended Medications
- Chemotherapy
- Immunotherapy
- Targeted Therapy
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Posterior Fossa Group B Ependymoma Differential Diagnosis
The differential diagnosis for posterior fossa group B ependymoma includes several conditions that can present with similar symptoms and imaging characteristics. According to the search results, these conditions include:
- Astrocytoma: A type of brain tumor that can occur in the posterior fossa and may present with seizures or focal neurological deficits [10].
- Medulloblastoma: A malignant brain tumor that is common in children and can occur in the posterior fossa. It may be considered in the differential diagnosis for posterior fossa group B ependymoma [14].
- Subependymoma: A rare type of brain tumor that arises from the ependymal cells lining the ventricles and may present with seizures or focal neurological deficits [14].
- Choroid plexus papilloma: A benign tumor that occurs in the choroid plexus, which is responsible for producing cerebrospinal fluid. It may be considered in the differential diagnosis for posterior fossa group B ependymoma [14].
It's worth noting that the differential diagnosis for posterior fossa group B ependymoma can vary depending on the specific characteristics of the tumor and the patient's symptoms.
References:
[10] Supratentorial ependymomas may also present with seizures or focal neurological deficits 2,5. [14] Imaging differential diagnosis · Medulloblastoma · Subependymoma · Choroid plexus papilloma.
Additional Differential Diagnoses
- Astrocytoma
- Subependymoma
- medulloblastoma
- choroid plexus papilloma
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4081
- owl#annotatedSource
- t361402
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#hasDbXref
- NCI:C186451
- oboInOwl#id
- DOID:0081255
- core#notation
- DOID:0081255
- oboInOwl#hasExactSynonym
- Posterior fossa group B (PFB) ependymoma
- rdf-schema#label
- posterior fossa group B ependymoma
- IAO_0000115
- A posterior fossa ependymoma that arises in the posterior fossa with characteristic DNA methylation patterns including retention of nuclear H3 p.K28me3 (K27me3) expression, absence of CpG island hypermethylation, absence of global DNA hypomethylation, and absence of EZHIP overexpression.
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0080889
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.